EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Trial Profile

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Riociguat (Primary)
  • Indications Pulmonary hypertension
  • Focus Adverse reactions
  • Acronyms EXPERT
  • Sponsors Bayer
  • Most Recent Events

    • 12 Jul 2017 Planned End Date changed from 1 Aug 2018 to 1 Jul 2018.
    • 19 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 May 2017 Interim results (n=713; As of July 10, 2016) presented at the 113th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top